DAWN 8-K 2026-01-12

Day One Biopharmaceuticals, Inc. (DAWN) 8-K dated 2026-01-12 — accession 0001193125-26-009834. This URL is the filing, not the DAWN hub.

Day One Biopharmaceuticals, Inc. (DAWN) is a biotechnology company listed on US.

Day One Biopharmaceuticals, Inc. filed a 8-K on 2026-01-12. Accession 0001193125-26-009834.

Cached items: 2.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported DAWN revenue for 2025-12-31 was $158.2M. Net income was -$107.3M. Revenue was up 20.6% from 2024-12-31 to 2025-12-31. DAWN currently screens at market cap $656.8M.

Not investment advice. The DAWN SEC hub lists recent forms. The stock page is the research view.